RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides With Positive ANCA After Relapse or Resistant Immunosuppressant Therapies InfliximabVersus Rituximab in Systemic Necrotizing Vasculitides With Positive ANCA After Relapse or ...
Phase II Pilot Cohort Study to Investigate the Safety and Efficacy of Infliximab as Additional Therapy in the Treatment if Anti-Neutrophil Cytoplasm Antibody Associated Vasculitis Phase II Pilot Cohort Study to Investigate the Safety and Efficacy of Infliximabas Additional Therap ...